Cargando…
Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
BACKGROUND AND OBJECTIVES: Inhibitors of sodium–glucose cotransporter 2 (SGLT2i) reduce the risk of hospitalization for heart failure (HF). We aimed to examine the effect of empagliflozin on change of diuretics dose in outpatient HF patients. METHODS: We retrospectively reviewed the medical records...
Autores principales: | Kim, Soo-Jin, Kim, Bong-Joon, Im, Sung-Il, Kim, Hyun-Su, Heo, Jung-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Heart Failure
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634028/ https://www.ncbi.nlm.nih.gov/pubmed/36381017 http://dx.doi.org/10.36628/ijhf.2022.0009 |
Ejemplares similares
-
Changes in QRS Duration Are Associated with a Therapeutic Response to Sacubitril–valsartan in Heart Failure with Reduced Ejection Fraction
por: Kim, Bong-Joon, et al.
Publicado: (2020) -
Increased Right Ventricular Pressure as a Predictor of Acute Decompensated Heart Failure in End-Stage Renal Disease Patients on Maintenance Hemodialysis
por: Kim, Bong-Joon, et al.
Publicado: (2022) -
Empagliflozin: Not just a glorified diuretic
por: John, Mathew
Publicado: (2016) -
Heart rate recovery and blood pressure response during exercise testing in patients with microvascular angina
por: Kim, Bong-Joon, et al.
Publicado: (2019) -
Real-time heart rate variability according to ambulatory glucose profile in patients with diabetes mellitus
por: Im, Sung Il, et al.
Publicado: (2023)